Immunology

1. Zahra Yazdani
2. Alireza Rafiei
3. Mohammadreza Yazdani
4. Reza Valadan

Reviewed by ScreenIT

Regulation of Angiotensin- Converting Enzyme 2 in Obesity: Implications for COVID-19

1. Saba Al Heialy
2. Mahmood Yaseen Hachim
3. Abiola Senok
4. Mellissa Gaudet
5. Ahmad Abou Tayoun
6. Rifat Hamoudi
7. Alawi Alsheikh-Ali
8. Qutayba Hamid

Reviewed by ScreenIT

Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray

1. Rafael R. de Assis
2. Aarti Jain
3. Rie Nakajima
4. Algis Jasinskas
5. Jiin Felgner
6. Joshua M. Obiero
7. Philip J. Norris
8. Mars Stone
9. Graham Simmons
10. Anil Bagri
11. Johannes Irsch
12. Martin Schreiber
13. Andreas Buser
14. Andreas Holbro
15. Manuel Battegay
16. Philip Hosimer
17. Charles Noesen
18. Oluwasanmi Adenaiye
19. Sheldon Tai
20. Filbert Hong
21. Donald K. Milton
22. D. Huw Davies
23. Paul Contestable
24. Laurence M. Corash
25. Michael P. Busch
26. Philip L. Felgner
27. Saahir Khan

Reviewed by ScreenIT

Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine

1. Mst Rubaiat Nazneen Akhand
2. Kazi Faizul Azim
3. Syeda Farjana Hoque
4. Mahmuda Akther Moli
5. Bijit Das Joy
6. Hafsa Akter
7. Ibrahim Khalil Afif
8. Nadim Ahmed
9. Mahmudul Hasan

Reviewed by ScreenIT

Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes

1. Michael J. Corley
2. Christopher Sugai
3. Michael Schotsaert
4. Robert E. Schwartz
5. Lishomwa C. Ndhlovu

Reviewed by ScreenIT

De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )

1. Veda Sheersh Boorla
2. Ratul Chowdhury
3. Ranjani Ramasubramanian
4. Brandon Ameglio
5. Rahel Frick
6. Jeffrey J. Gray
7. Costas D. Maranas

Reviewed by ScreenIT

Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy

1. Bette S. Pollard
2. Jorge C. Blanco
3. John R. Pollard
4. Gregory A. Prince

Reviewed by ScreenIT

Currently Available Intravenous Immunoglobulin Contains Antibodies Reacting Against Severe Acute Respiratory Syndrome Coronavirus 2 Antigens

1. José-María Díez
2. Carolina Romero
3. Rodrigo Gajardo

Reviewed by ScreenIT

Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition

1. Oliver C. Grant
2. David Montgomery
3. Keigo Ito
4. Robert J. Woods

Reviewed by ScreenIT

JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome

1. Kathryn D. Tuttle
2. Katherine A. Waugh
3. Paula Araya
4. Ross Minter
5. David J. Orlicky
6. Michael Ludwig
7. Zdenek Andrysik
8. Matthew A. Burchill
9. Beth A.J. Tamburini
10. Colin Sempeck
11. Keith Smith
12. Ross Granrath
13. Dayna Tracy
14. Jessica Baxter
15. Joaquin M. Espinosa
16. Kelly D. Sullivan

Reviewed by ScreenIT